Advertisement

Topics

Catalyst Advisors, L.P. Company Profile

22:31 EDT 17th October 2018 | BioPortfolio

Catalyst Advisors helps high-growth life sciences companies identify and attract the transformative board members, CEOs and other senior leaders needed to successfully navigate critical inflection points in the corporate trajectory. The firm has offices in New York, London and Los Angeles. For more information, please visit www.catalystadvisorslp.com and follow Catalyst Advisors, L.P. on LinkedIn.


News Articles [410 Associated News Articles listed on BioPortfolio]

Catalyst Biosciences Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 28072018] Prices from USD $350

Catalyst Biosciences Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Catalyst Biosciences Inc Mergers Acquisitions MA, Partnerships Alliances and Inve...

Catalyst Biosciences Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 30032018] Prices from USD $350

Catalyst Biosciences Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Catalyst Biosciences Inc Mergers Acquisitions MA, Partnerships Alliances and Inve...

Catalyst Biosciences Inc Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Report Updated: 23042018] Prices from USD $350

Catalyst Biosciences Inc Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Catalyst Biosciences Inc Mergers Acquisitions MA, Partnerships Alliances and Inve...

A simple catalyst helps to assemble complex molecular frameworks of antifungal agents

(AKSON Russian Science Communication Association) A team of Russian chemists led by Professor Dmitry Perekalin from Nesmeyanov Institute of Organoelement Compounds have recently developed a new rhodiu...

InvestmentNews Names Miracle Mile Advisors Among Top 50 Best Places to Work for Financial Advisors

"I wanted to build a firm where everyone looks forward to Mondays, and advisors could provide meaningful, incomparable advice," said Brock Moseley, founder of Read more...

Catalyst seeks FDA nod for Lambert-Eaton myasthenic syndrome therapy

Catalyst Pharmaceuticals filed a new drug application with the FDA seeking approval for Firdapse, or amifampridine, which is  -More- 

A ruthenium-based catalyst with highly active, flat surfaces outperforms metal-based competitors

Scientists in Japan and India have developed a reusable, high-performance catalyst based on flat-shaped ruthenium nanoparticles (Ru-NP) for the production of valuable chemicals. Due to its demonstrate...

Catalyst Pharmaceuticals Announces FDA Acceptance of NDA and Priority Review Status for Firdapse

Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromusc...

Drugs and Medications [0 Results]

None

PubMed Articles [442 Associated PubMed Articles listed on BioPortfolio]

Salutogenic service user involvement in nursing research: a case study.

The aim was to explore the process of involving mental healthcare service users in a mental health promotion research project as research advisors and to articulate features of the collaboration which...

Silicon carbide foam supported ZSM-5 composite catalyst for microwave-assisted pyrolysis of biomass.

Considering a series of issues facing the application of catalysts in large scale catalytic fast pyrolysis systems, a novel composite catalyst of ZSM-5 coatings on SiC foam supports was developed and ...

Selective CO Evolution from Photoreduction of CO2 on a Metal-Carbide-Based Composite Catalyst.

A selective CO evolution from photoreduction of CO2 in wa-ter was achieved on a noble-metal-free, carbide-based compo-site catalyst, as demonstrated by a CO selectivity of 98.3% among all carbon-conta...

Excellent activity and selectivity of one-pot synthesized Cu-SSZ-13 catalyst in the selective catalytic oxidation of ammonia to nitrogen.

One-pot synthesized Cu-SSZ-13 catalyst treated with dilute HNO3 achieved superior activity and selectivity in the selective catalytic oxidation (SCO) of NH3 to nitrogen, in comparison with other zeoli...

Planar-chiral rhodium(III) catalyst with sterically demanding cyclopentadienyl ligand and its application for enantioselective synthesis of dihydroisoquinolones.

Rapid development of enantioselective CH-activation reactions created a demand for new types of catalysts. Herein we report the synthesis of a novel planar-chiral rhodium catalyst [(C5H2tBu2CH2tBu)RhI...

Clinical Trials [11 Associated Clinical Trials listed on BioPortfolio]

Lay Health Advisors for Sexually Transmitted Disease Prevention

Non-professional community leaders may be at a great advantage in reaching otherwise hard to reach populations for the purpose of advising on sexually transmitted disease (STD) prevention ...

Using Lay Health Advisors to Improve Hypertension Management

Hypertension disproportionately affects and is inadequately controlled among African American and poor populations. The investigators propose to determine the impact of using trained lay h...

Trial of Health at Work Workplace Health Intervention

This pilot study will compare workplace health intervention delivered by advisors based in GP practices with normal GP care to assess the usefulness of the concept and its potential for wi...

A SU2C Catalyst® Trial of a PD1 Inhibitor With or Without a Vitamin D Analog for the Maintenance of Pancreatic Cancer

Chemotherapy regimens for pancreatic cancer can now stabilize a patient's cancer and/or place some patients in remission or partial remission. The challenge now is to find options for main...

Telehealth Depression Treatments for Older Adults

This study aims to find an effective and sustainable approach to reducing disparities in accessing mental health services for an underserved and growing population group of low-income, rac...

Companies [335 Associated Companies listed on BioPortfolio]

Catalyst Advisors, L.P.

Catalyst Advisors helps high-growth life sciences companies identify and attract the transformative board members, CEOs and other senior leaders needed to successfully navigate cr...

Catalyst Advisors

Catalyst Advisors is a premier executive search firm devoted to finding exceptional boardroom and executive leaders for innovative healthcare and bioscience companies, including t...

Clearsight Advisors

Clearsight Advisors is an independent merchant banking firm dedicated to providing world-class M&A and capital raising solutions exclusively to growth-oriented Business Services a...

Catalyst Health and Technology Partners

Catalyst Health and Technology Partners (“Catalyst”), is a venture capital firm dedicated to helping promising early-stage health care, life science, and technology ventures grow.Catalyst is focus...

General Catalyst Partners

General Catalyst Partners is a growth equity and venture capital firm that invests in exceptional entrepreneurs who are building the technology-based companies that will lead inno...

More Information about "Catalyst Advisors, L.P." on BioPortfolio

We have published hundreds of Catalyst Advisors, L.P. news stories on BioPortfolio along with dozens of Catalyst Advisors, L.P. Clinical Trials and PubMed Articles about Catalyst Advisors, L.P. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Catalyst Advisors, L.P. Companies in our database. You can also find out about relevant Catalyst Advisors, L.P. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record